跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
IPCA-CITALOPRAM citalopram (as hydrobromide) 10 mg tablet bottle
Approved
STANDARD
IPCA-CITALOPRAM citalopram (as hydrobromide) 10 mg tablet bottle
Ipca Pharma (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
5ea86936fb1bca07
Company
Ipca Pharma (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
5ea86936fb1bca07
Product Name
IPCA-CITALOPRAM citalopram (as hydrobromide) 10 mg tablet bottle
Artg Id
158869
Artg Name
IPCA-CITALOPRAM citalopram (as hydrobromide) 10 mg tablet bottle
Sponsor
Ipca Pharma (Australia) Pty Ltd
Company Detail Path
/organization/ipca-pharma-australia-pty-ltd
Artg Date
2010-02-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
5ea86936fb1bca07
Type
Standard
Back to TGA Approvals
IPCA-CITALOPRAM citalopram (as hydrobromide) 10 mg tablet bottle - TGA Drug Approval Details
